Sartorius Aktiengesellschaft (OTCMKTS:SARTF - Get Free Report) was the target of a large decline in short interest during the month of February. As of February 15th, there was short interest totalling 2,400 shares, a decline of 14.3% from the January 31st total of 2,800 shares. Based on an average trading volume of 100 shares, the days-to-cover ratio is presently 24.0 days.
Wall Street Analysts Forecast Growth
SARTF has been the topic of a number of recent analyst reports. Guggenheim raised Sartorius Aktiengesellschaft to a "strong-buy" rating in a report on Thursday, December 19th. Wolfe Research raised Sartorius Aktiengesellschaft to a "strong-buy" rating in a report on Thursday, November 14th.
Get Our Latest Stock Report on SARTF
Sartorius Aktiengesellschaft Price Performance
Shares of SARTF stock remained flat at $196.00 during trading on Friday. The company has a quick ratio of 1.13, a current ratio of 2.02 and a debt-to-equity ratio of 1.17. The stock has a market cap of $6.71 billion, a PE ratio of 148.49 and a beta of 1.11. Sartorius Aktiengesellschaft has a 52 week low of $175.93 and a 52 week high of $299.94. The firm has a 50 day simple moving average of $208.22 and a two-hundred day simple moving average of $203.47.
Sartorius Aktiengesellschaft (OTCMKTS:SARTF - Get Free Report) last released its quarterly earnings results on Monday, February 17th. The company reported $1.11 earnings per share (EPS) for the quarter. The business had revenue of $967.37 million during the quarter. Sartorius Aktiengesellschaft had a return on equity of 7.33% and a net margin of 2.48%.
About Sartorius Aktiengesellschaft
(
Get Free Report)
Sartorius Aktiengesellschaft provides bioprocess solutions and lab products and services in the United States and internationally. The company offers multi-parallel, benchtop, single-use, stainless steel, cell culture, rocking motion, and microbial bioreactors, and software apps for bioreactors and cell culture shake flask; fermenters; cell culture media products; cellcelector flex, incubator flowbox, nanowell arrays, and capillaries and tips; fluid management products; microbiology products; and Ultrafiltration membrane filters, glass and quartz microfiber filters, clarification, syringeless and in-line filters, lab chromatography, and filters and blotting papers.
Further Reading
Before you consider Sartorius Aktiengesellschaft, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sartorius Aktiengesellschaft wasn't on the list.
While Sartorius Aktiengesellschaft currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
